Evidence map›Paper›PMID 36414617›Full record

ArticleNature communications2022

Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient.

Rachel M Wheatley, Julio Diaz Caballero, Thomas E van der Schalk, Fien H R De Winter, Liam P Shaw, Natalia Kapel, Claudia Recanatini, Leen Timbermont, Jan Kluytmans, Mark Esser and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Deletion ofApplied and environmental microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. mBio · 2025
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rachel M Wheatley *University of Oxford, Department of Biology, Oxford, UK.ORCID 0000-0003-1212-2286
Julio Diaz Caballero *University of Oxford, Department of Biology, Oxford, UK.
Thomas E van der SchalkLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.ORCID 0000-0001-7493-4082
Fien H R De WinterMolecular Pathology Group, Laboratory of Cell Biology and Histology, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.ORCID 0000-0003-3803-7813
Liam P ShawUniversity of Oxford, Department of Biology, Oxford, UK.
Natalia KapelUniversity of Oxford, Department of Biology, Oxford, UK.
Claudia RecanatiniJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-0643-7599
Leen TimbermontLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.ORCID 0000-0002-9543-9205
Jan KluytmansJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Mark EsserMicrobial Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0003-1689-3475
Alicia LacomaMicrobiology Department, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias, Universitat Autònoma de Barcelona, Badalona, Spain.
Cristina Prat-AymerichJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0001-6974-9165
Antonio OliverServicio de Microbiología, Hospital Universitari Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.
Samir Kumar-SinghLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.ORCID 0000-0001-9466-6732
Surbhi Malhotra-KumarLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.ORCID 0000-0001-8699-8905
R Craig MacLeanUniversity of Oxford, Department of Biology, Oxford, UK. craig.maclean@biology.ox.ac.uk.ORCID 0000-0002-7941-813X

Funding

Wellcome Trust 106918/Z/15/ZWellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

Bacteria have the potential to translocate between sites in the human body, but the dynamics and consequences of within-host bacterial migration remain poorly understood. Here we investigate the link between gut and lung Pseudomonas aeruginosa populations in an intensively sampled ICU patient using a combination of genomics, isolate phenotyping, host immunity profiling, and clinical data. Crucially, we show that lung colonization in the ICU was driven by the translocation of P. aeruginosa from the gut. Meropenem treatment for a suspected urinary tract infection selected for elevated resistance in both the gut and lung. However, resistance was driven by parallel evolution in the gut and lung coupled with organ specific selective pressures, and translocation had only a minor impact on AMR. These findings suggest that reducing intestinal colonization of Pseudomonas may be an effective way to prevent lung infections in critically ill patients.

Indexed as

Anti-Bacterial AgentsPseudomonas aeruginosaBacteriaHumansIntensive Care UnitsLungMeropenemAnti-Bacterial AgentsMeropenem

Identifiers

PMID36414617
PMCPMC9681761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.